Free Trial
NASDAQ:BBNX

Beta Bionics (BBNX) Stock Price, News & Analysis

Beta Bionics logo
$18.04 +0.59 (+3.38%)
As of 02:58 PM Eastern

About Beta Bionics Stock (NASDAQ:BBNX)

Key Stats

Today's Range
$17.43
$18.50
50-Day Range
$12.53
$18.23
52-Week Range
$8.89
$24.50
Volume
203,713 shs
Average Volume
528,925 shs
Market Capitalization
$784.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.56
Consensus Rating
Moderate Buy

Company Overview

Receive BBNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beta Bionics and its competitors with MarketBeat's FREE daily newsletter.

BBNX Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.tc pixel
See More Headlines

BBNX Stock Analysis - Frequently Asked Questions

Beta Bionics' stock was trading at $23.81 at the beginning of 2025. Since then, BBNX stock has decreased by 24.6% and is now trading at $17.96.

Beta Bionics, Inc. (NASDAQ:BBNX) announced its earnings results on Tuesday, July, 29th. The company reported ($0.39) earnings per share for the quarter, beating the consensus estimate of ($0.51) by $0.12. The company had revenue of $23.24 million for the quarter, compared to analyst estimates of $19.73 million.
Read the conference call transcript
.

Beta Bionics (BBNX) raised $204 million in an initial public offering (IPO) on Thursday, January 30th 2025. The company issued 12,000,000 shares at a price of $17.00 per share.

Beta Bionics's lock-up period expired on Tuesday, July 29th. Beta Bionics had issued 12,000,000 shares in its IPO on January 30th. The total size of the offering was $204,000,000 based on an initial share price of $17.00. Shares of the company owned by major shareholders and company insiders are now eligible to be traded as a result of the expiration of the lock-up period.

Beta Bionics' top institutional investors include Eventide Asset Management LLC (11.35%), Soleus Capital Management L.P. (8.79%), Sands Capital Alternatives LLC (8.21%) and Divisadero Street Capital Management LP (2.18%). Insiders that own company stock include Hadley Harbor Aggre Wellington, Mike Mensinger, Steven Jon Russell, Stephen Feider and Mark Hopman.
View institutional ownership trends
.

Shares of BBNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
7/29/2025
Today
8/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BBNX
Previous Symbol
NASDAQ:BBNX
CIK
1674632
Web
N/A
Fax
N/A
Employees
294
Year Founded
N/A

Price Target and Rating

High Price Target
$30.00
Low Price Target
$16.00
Potential Upside/Downside
+29.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
14.68
Quick Ratio
13.79

Sales & Book Value

Annual Sales
$78.02 million
Price / Sales
9.72
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($5.72) per share
Price / Book
-3.05

Miscellaneous

Outstanding Shares
43,470,000
Free Float
N/A
Market Cap
$758.55 million
Optionable
N/A
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:BBNX) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners